Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterasesDeobrat Dixit, Jeremy N. Rich, Qiulian Wu et al.|Science Translational Medicine|2022Cited by 37